Adjuvant high dose rate brachytherapy for soft tissue sarcomas: initial experience report

PURPOSE: Adjuvant high-dose-rate brachytherapy (HDRBT) offers advantages over low dose rate brachytherapy (LDRBT), although there are little data on local tumor control and treatment related toxicity. We report outcome in patients with primary, recurrent, and metastatic extremity and superficial tru...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, Julie A., Kleinman, Sara H., Rownd, Jason, King, David, Hackbarth, Donald, Whitfield, Robert, Wang, Dian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108830/
https://www.ncbi.nlm.nih.gov/pubmed/27877194
http://dx.doi.org/10.5114/jcb.2011.21036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108830/
https://www.ncbi.nlm.nih.gov/pubmed/27877194
http://dx.doi.org/10.5114/jcb.2011.21036

Ejemplares similares